您当前的位置:
首页 >
文章列表页 >
Study on the mechanism of oridonin to reverse drug resistance of breast cancer cell MCF- 7 to fulvestrant
更新时间:2022-11-09
    • Study on the mechanism of oridonin to reverse drug resistance of breast cancer cell MCF- 7 to fulvestrant

    • China Pharmacy   Vol. 33, Issue 17, (2022)
    • Published:2022

    扫 描 看 全 文

  • HU Gaobo, ZHU Rui, JIN Zhan, et al. Study on the mechanism of oridonin to reverse drug resistance of breast cancer cell MCF- 7 to fulvestrant. [J]. China Pharmacy 33(17).(2022) DOI:

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Current status and prospect of composite nano-phototherapy agents in the phototherapy for breast cancer treatment
右美托咪定在乳腺癌前哨淋巴结活检术中的临床应用
酪氨酸激酶类药物治疗乳腺癌的研究进展
阿仑膦酸钠联合化疗对乳腺癌骨转移患者骨代谢的影响
临床药师参与1例炎性乳腺癌患者新辅助化疗的药学监护

Related Author

YAN Bin
YANG Mingrui
WANG Shangzhi
ZHANG Jin
甘建辉 史金麟 胡万宁 叶玉军
张亚 李亚龙 李荣杰
林立忠 林仁志 潘 印
李静姿 向 倩 周 颖 崔一民

Related Institution

School of Pharmacy, Shandong University of Traditional Chinese Medicine
College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine
0